Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Blog Examines Debate Surrounding High Cost Of Hepatitis C Drug

The Center for Global Health Policy’s “Science Speaks” blog summarizes ongoing debate surrounding the high cost of a newly approved and highly effective treatment for Hepatitis C. “…[T]he drug shortens treatment for chronic hepatitis C from 48 weeks to 12, and offers a 90 percent cure rate, at more than $80,000 for a course of treatment,” the blog notes (Barton, 2/10).